{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T22:54:14Z","timestamp":1788648854721,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.transproceed.2021.08.042","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T12:57:05Z","timestamp":1633352225000},"page":"2678-2680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Institutional Experience With New Antidiabetic Drugs in Kidney Transplant"],"prefix":"10.1016","volume":"53","author":[{"given":"Alejandra","family":"Yugueros Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gavela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2721-6920","authenticated-orcid":false,"given":"Eva","family":"Sol\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Pallard\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2021.08.042_bib0001","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2213-8587(15)00387-3","article-title":"Post-transplantation diabetes\u2014state of the art","volume":"4","author":"Sharif","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0002","first-page":"21","article-title":"Treatment of diabetes mellitus after transplantation. Prometheus consensus","volume":"1","author":"Delgado","year":"2010","journal-title":"Nephrology"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0003","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1159\/000481375","article-title":"Dynamics of glucose metabolism after kidney transplantation","volume":"42","author":"Guthoff","year":"2017","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1025893","article-title":"Management strategies for posttransplant diabetes mellitus after heart transplantation: a review","volume":"2018","author":"Cehic","year":"2018","journal-title":"J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0005","first-page":"34","article-title":"Consensus document on the treatment of type 2 diabetes in patients with chronic kidney disease","volume":"34","author":"G\u00f3mez-Huelgas","year":"2014","journal-title":"Nefrologia"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0006","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrneph.2017.123","article-title":"GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes","volume":"13","author":"Muskiet","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0007","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1365-2125.2009.03536.x","article-title":"Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide","volume":"68","author":"Jacobsen","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-13-102","article-title":"Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOMETM)","volume":"13","author":"Zinman","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.trre.2016.09.001","article-title":"Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus","volume":"31","author":"Vanhove","year":"2017","journal-title":"Transplant Rev"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2337\/dc13-1066","article-title":"Coadministration of liraglutide with tacrolimus in kidney transplant recipients: a case series","volume":"36","author":"Pinelli","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20133152","article-title":"Management of diabetes mellitus in normal renal function, renal dysfunction and renal transplant recipients, focusing on glucagon-like peptide-1 agonist: a review based upon current evidence","volume":"20","author":"Tsai","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0012","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.transproceed.2018.03.087","article-title":"Management of diabetes mellitus with glucagonlike peptide-1 agonist liraglutide in renal transplant recipients: a retrospective study","volume":"50","author":"Liou","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0013","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ijo.2016.52","article-title":"Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial","volume":"40","author":"Blackman","year":"2016","journal-title":"Int J Obes"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0014","first-page":"2271","article-title":"The role of GLP-1 analogs in the treatment of obesity","volume":"2","author":"Lecube","year":"2018","journal-title":"BMI J"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0015","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.TP.0000120949.86038.62","article-title":"Weight gain after renal transplantation is a risk factor for patient and graft outcome","volume":"77","author":"El-Agroudy","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0016","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s13300-020-00786-1","article-title":"A retrospective study of glucagon-like peptide 1 receptor agonists for the management of diabetes after transplantation","volume":"11","author":"Thangavelu","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0017","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1097\/TXD.0000000000000971","article-title":"The use of GLP1R agonists for the treatment of type 2 diabetes in kidney transplant recipients","volume":"6","author":"Kukla","year":"2020","journal-title":"Transplant Direct"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0018","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/ajt.15223","article-title":"Empagliflozin in posttransplantation diabetes mellitus: a prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety","volume":"19","author":"Schwaiger","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0019","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1159\/000501854","article-title":"Sodium-glucose cotransporter 2 (SGLT2) inhibition in kidney transplant recipients with diabetes mellitus","volume":"44","author":"Mahling","year":"2019","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.transproceed.2021.08.042_bib0020","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/dc19-0093","article-title":"Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus","volume":"42","author":"Str\u00f8m Halden","year":"2019","journal-title":"Diabetes Care"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521006308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521006308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:38:54Z","timestamp":1758577134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134521006308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0041134521006308"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.08.042","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Institutional Experience With New Antidiabetic Drugs in Kidney Transplant","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}